Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network–Based Artificial Intelligence Tool The best performing model, a Bi-LSTM NER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback